Results suggest drug could particularly benefit “emotional eaters”
A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center (BIDMC) reported. In the first study of the drug lorcaserin in the human brain, the research revealed teh mechanism underlying the drug’s efficacy and provides inside into which individuals may benefit most from the medication. To read more, click here.
o 
o
